Webinars
WEBINAR: Advancing Neurodegenerative and Neurodevelopmental Drug Discovery by Investigating iPSC-derived Excitatory Neurons Using Automated Patch Clamp
March 27, 2025 | 11:00 AM CST
Scott Schachtele, Kadla Rosholm
Join us on March 27, 2025 (at 4:00 PM CET) for our exclusive two-part webinar on: Advancing neurodegenerative and neurodevelopmental drug discovery by investigating iPSC-derived excitatory neurons using automated patch clamp. What you'll learn in the Neurons webinar: Part 1: Development and characterization of human iPSC-derived induced excitatory neurons for disease modeling and drug discovery [...]
Find out More
WEBINAR: Neurodegeneration at the Cellular Level: Organelles in the Spotlight
March 25, 2025 | 11:00AM EST
Scott Schachtele, Silvia Cainarca
Organelles are specialized structures within cells that play a crucial role in maintaining homeostasis by regulating essential cellular processes such as energy production, protein synthesis, and waste removal. Dysfunction of these organelles can disrupt normal cellular functions, contributing to the development and progression of various diseases, including neurodegenerative disorders like Parkinson’s Disease (PD) and Amyotrophic [...]
Find out More
WEBINAR: Interrogating cell signaling pathways in iPSC-derived microglia to understand Alzheimer’s disease pathology
February 4, 2025 | 10:00 AM CSTTuesday, February 4th, 2025 • 10:00 AM CST Microglia, the brain's resident immune cells, play a critical role in mediating inflammatory responses within the central nervous system or CNS. They also contribute to recognizing and eliminating foreign invaders, as well as repairing damaged CNS tissue after injury. TREM2, a receptor protein expressed on the microglia [...]
Find out More
WEBINAR: Engineered Heart Tissues for Evaluating Safety & Efficacy of Gene Therapies
December 4, 2024 | 10:00 AM CSTMyoPod® Engineered Heart Tissues using iCell® Cardiomyocytes are physiologically relevant in vitro models for evaluating safety and efficacy of vector-based gene therapies. Wednesday, December 4th, 2024 • 10:00 AM CST MyoPod® Engineered Heart Tissues (EHT) are fully functional, mature, and machine-readable cardiac tissues generated by seeding human iPSC derived cardiomyocytes into decellularized myocardial matrix. The EHTs [...]
Find out More
WEBINAR: Scientific Shorts: Neuroscience 2024 Poster Recap with New iPSC-derived Cell Types and Applications
October 23, 2024 | 11:00 AM CSTDuring this webinar, we reviewed the exciting scientific research FCDI presented at Neuroscience 2024 as four 10-minute talks. Key topics include: Optimization of cytokine release assays for iCell® Microglia and the role of healthy microglia and TREM2 variants in neuroprotection and neurodegeneration. Assays to evaluate iCell Sensory Neurons function and techniques to investigate immune-mediated neuropathic [...]
Find out More
WEBINAR: iPSCs and Neurodegeneration: Establishing relevant cellular models and assays for advancing drug discovery
September 17, 2024 | 9:00 AM CSTNeurodegenerative diseases continue to be a challenge in the development of effective drug treatments by the pharmaceutical industry. This is due to the diversity of genetics and environmental factors that impact disease risk as well as the difficulty in modeling the complex anatomy and interplay of brain cells in vitro. Human induced pluripotent stem cell [...]
Find out More
WEBINAR: Exploring Immune-mediated Toxicity with iCell® Macrophages 2.0
May 21, 2024 | 10:00 AM CSTMacrophages are present throughout every tissue type in the human body. They play important roles in maintaining homeostasis, immune surveillance, tissue repair, and debris clearance. In this webinar, we will showcase the first-to-market source of full function, cryopreserved, human iPSC-derived macrophages. These cells, iCell Macrophages 2.0, can be used in a variety of applications and [...]
Find out More
iForum™ Innovation Showcase 2024: Implementing Human iPSC Models to Speed Drug Discovery and Improve Clinical Translation.
January 30, 2024 | 8:00 AM CSTJoin FCDI scientists for an informative presentation and discussion on advancing drug discovery across cardiac, hepatic, neural, and immune systems. We will share data-driven examples and case studies, leveraging FCDI’s recently developed platforms. Each discussion will be chock full of insights, takeaways, and opportunities for future implementation. iCell Macrophages 2.0 - Full Function, Cryopreserved Macrophages [...]
Find out More
WEBINAR – Assaying with iPSC-derived Cardiomyocytes: Setting the Rhythm for Early Drug Discovery
November 8, 2023 | 10:00 AM CSTCardiotoxicity is one of the most common adverse drug effects as unwanted drug interactions with cardiac ion channels could induce lethal arrhythmias by affecting cardiac electrophysiology. For these reasons, physiological assays that measure cardiomyocyte function are particularly important to reveal drug effects and discover new therapeutic targets. Human iPSC-derived cardiac cell models enable recapitulation of [...]
Find out More
- Upcoming Webinars
-
No Upcoming Webinars Please Sign Up To Our Newsletter For Updates!
No Upcoming Webinars Please Sign Up To Our Newsletter For Updates!
No Upcoming Webinars Please Sign Up To Our Newsletter For Updates!
No Upcoming Webinars Please Sign Up To Our Newsletter For Updates!
No Upcoming Webinars Please Sign Up To Our Newsletter For Updates!
- Past Webinars
-
WEBINAR: Advancing Neurodegenerative and Neurodevelopmental Drug Discovery by Investigating iPSC-derived Excitatory Neurons Using Automated Patch Clamp
March 27, 2025 | 11:00 AM CSTScott Schachtele, Kadla Rosholm
Join us on March 27, 2025 (at 4:00 PM CET) for our exclusive two-part webinar on: Advancing neurodegenerative and neurodevelopmental drug discovery by investigating iPSC-derived excitatory neurons using automated patch clamp. What you'll learn in the Neurons webinar: Part 1: Development and characterization of human iPSC-derived induced excitatory neurons for disease modeling and drug discovery [...]Find out MoreWEBINAR: Neurodegeneration at the Cellular Level: Organelles in the Spotlight
March 25, 2025 | 11:00AM ESTScott Schachtele, Silvia Cainarca
Organelles are specialized structures within cells that play a crucial role in maintaining homeostasis by regulating essential cellular processes such as energy production, protein synthesis, and waste removal. Dysfunction of these organelles can disrupt normal cellular functions, contributing to the development and progression of various diseases, including neurodegenerative disorders like Parkinson’s Disease (PD) and Amyotrophic [...]Find out MoreWEBINAR: Interrogating cell signaling pathways in iPSC-derived microglia to understand Alzheimer’s disease pathology
February 4, 2025 | 10:00 AM CSTTuesday, February 4th, 2025 • 10:00 AM CST Microglia, the brain's resident immune cells, play a critical role in mediating inflammatory responses within the central nervous system or CNS. They also contribute to recognizing and eliminating foreign invaders, as well as repairing damaged CNS tissue after injury. TREM2, a receptor protein expressed on the microglia [...]Find out MoreWEBINAR: Engineered Heart Tissues for Evaluating Safety & Efficacy of Gene Therapies
December 4, 2024 | 10:00 AM CSTMyoPod® Engineered Heart Tissues using iCell® Cardiomyocytes are physiologically relevant in vitro models for evaluating safety and efficacy of vector-based gene therapies. Wednesday, December 4th, 2024 • 10:00 AM CST MyoPod® Engineered Heart Tissues (EHT) are fully functional, mature, and machine-readable cardiac tissues generated by seeding human iPSC derived cardiomyocytes into decellularized myocardial matrix. The EHTs [...]Find out MoreWEBINAR: Scientific Shorts: Neuroscience 2024 Poster Recap with New iPSC-derived Cell Types and Applications
October 23, 2024 | 11:00 AM CSTDuring this webinar, we reviewed the exciting scientific research FCDI presented at Neuroscience 2024 as four 10-minute talks. Key topics include: Optimization of cytokine release assays for iCell® Microglia and the role of healthy microglia and TREM2 variants in neuroprotection and neurodegeneration. Assays to evaluate iCell Sensory Neurons function and techniques to investigate immune-mediated neuropathic [...]Find out MoreWEBINAR: iPSCs and Neurodegeneration: Establishing relevant cellular models and assays for advancing drug discovery
September 17, 2024 | 9:00 AM CSTNeurodegenerative diseases continue to be a challenge in the development of effective drug treatments by the pharmaceutical industry. This is due to the diversity of genetics and environmental factors that impact disease risk as well as the difficulty in modeling the complex anatomy and interplay of brain cells in vitro. Human induced pluripotent stem cell [...]Find out MoreWEBINAR: Exploring Immune-mediated Toxicity with iCell® Macrophages 2.0
May 21, 2024 | 10:00 AM CSTMacrophages are present throughout every tissue type in the human body. They play important roles in maintaining homeostasis, immune surveillance, tissue repair, and debris clearance. In this webinar, we will showcase the first-to-market source of full function, cryopreserved, human iPSC-derived macrophages. These cells, iCell Macrophages 2.0, can be used in a variety of applications and [...]Find out MoreiForum™ Innovation Showcase 2024: Implementing Human iPSC Models to Speed Drug Discovery and Improve Clinical Translation.
January 30, 2024 | 8:00 AM CSTJoin FCDI scientists for an informative presentation and discussion on advancing drug discovery across cardiac, hepatic, neural, and immune systems. We will share data-driven examples and case studies, leveraging FCDI’s recently developed platforms. Each discussion will be chock full of insights, takeaways, and opportunities for future implementation. iCell Macrophages 2.0 - Full Function, Cryopreserved Macrophages [...]Find out MoreWEBINAR – Assaying with iPSC-derived Cardiomyocytes: Setting the Rhythm for Early Drug Discovery
November 8, 2023 | 10:00 AM CSTCardiotoxicity is one of the most common adverse drug effects as unwanted drug interactions with cardiac ion channels could induce lethal arrhythmias by affecting cardiac electrophysiology. For these reasons, physiological assays that measure cardiomyocyte function are particularly important to reveal drug effects and discover new therapeutic targets. Human iPSC-derived cardiac cell models enable recapitulation of [...]Find out More
